Lamberto Andreotti

Type: Person
Name: Lamberto Andreotti
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

CEO’s Letter: The stubborn facts about the 100 Best Corporate Citizens List

CEO’s Letter: The stubborn facts about the 100 Best Corporate Citizens ListElliot H. Clark, CEO“Facts are stubborn things; and whatever may be our wishes, our inclinations, or the dictates of our passion, they cannot alter the state of facts and evid ... [Published CRO - Jul 09 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 2 reports

Bristol-Myers Squibb Treatment for Hepatitis C Approved

Tweet[embedded content]Japan approved the all-oral Sunvepra and Daklinzadual regimen from Bristol-Myers Squibb to treat those with hepatitis C, said the company on Monday.The combo-treatment, which is ribavirin- and interferon-free is the latest options ... [Published Zolmax News - Jul 07 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Bristol-Myers' hep C combo wins Japanese OK, leading the pack

Bristol-Myers Squibb ($BMY) has become the first drugmaker to win regulatory approval for a combination hepatitis C treatment that doesn't require painful injections, picking up a Japanese nod for its all-oral cocktail.The country's Ministry of Health, ... [Published FierceBiotech - Jul 07 2014]
First reported Jun 27 2014 - Updated Jun 28 2014 - 1 reports

Eliquis scores DVT/PE recommendation in Europe

Right now, Eliquis, the new-age clot-fighter from Pfizer ($PFE) and Bristol-Myers Squibb ($BMY), is in third place in a three-horse race. But as it tries to catch up to rivals Pradaxa and Xarelto--not to mention the $3-billion-per-year sales forecasts ... [Published FiercePharma - Jun 27 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

Giovanni Caforio, M.D., Appointed Chief Operating Officer and Elected to Board of Directors

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- Bristol-Myers Squibb Company (NYSE:BMY) announced that Giovanni Caforio, M.D., has been appointed chief operating officer and elected to Bristol-Myers Squibb's Board of Directors, ... [Published NewsRX - Jun 20 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 1 reports

U.K. price watchdog weighs in on BMS melanoma blockbuster Yervoy

Three months after Britain's National Institute for Health and Care Excellence (NICE) said it would not recommend Bristol-Myers Squibb's ($BMY) Yervoy as a first-line treatment for melanoma, the much-feared cost-effectiveness agency has changed its mind. ... [Published FiercePharma - Jun 13 2014]
First reported Jun 09 2014 - Updated Jun 10 2014 - 3 reports

Bristol-Myers Squibb names new chief operating officer

:04 in Pharmaceutical Company Restructures Bristol-Myers Squibb has announced the appointment of Dr Giovanni Caforio as its new chief operating officer, a role that will also seem him become a member of the firm's board of directors. He has been with ... [Published Zenopa - Jun 10 2014]
First reported Jun 04 2014 - Updated Jun 04 2014 - 1 reports

DuPont Co. Sued for $1 Billion Over Genetic Technology

DuPont Co. (DD) , the maker of Pioneergenetically modified corn, was sued for $1 billion by aninvestment fund that claims company directors promotedherbicide-resistant crop traits knowing they didn’t work.The Ironworkers District Council of Philadelphia ... [Published Bloomberg - Jun 04 2014]
First reported Apr 30 2014 - Updated Apr 30 2014 - 1 reports

Bristol-Myers Squibb's (BMY) CEO John Elicker on Q1 2014 Earnings - Call Transcript

This transcript originally appeared on Seeking Alpha.Title: Bristol-Myers Squibb's CEO Discusses Q1 2014 Results - Earnings Call Transcript Symbol: BMYCall Start: 09:00Call End: 09:58Bristol-Myers Squibb Company (BMY)Q1 2014 Earnings Conference CallApril ... [Published The Street Latest - Apr 30 2014]
First reported Apr 30 2014 - Updated Apr 30 2014 - 1 reports

Bristol-Myers Squibb net earnings up by 54% in Q1

Bristol-Myers Squibb has posted strong growth in its net earnings during the first quarter ended March 2014 despite lower sales. The net earnings improved by 53.9 per cent to US$ 937 million from $609 million in the similar quarter of last year with significant ... [Published PharmaBiz - Apr 30 2014]
First reported Jan 27 2014 - Updated Jan 27 2014 - 1 reports

Bristol-Myers Squibb net falls by 21.5% in Q4

Bristol-Myers Squibb Company has posted lower net profit of US$ 726 million during the fourth quarter ended December 2013 as against $925 million in the corresponding period of last year. Its net product sales increased by 6.9 per cent to $3,298 million ... [Published PharmaBiz - Jan 27 2014]
First reported Jan 20 2014 - Updated Jan 20 2014 - 1 reports

J.P. Morgan: Pharma’s Agenda for 2014

Presenters at the 32 nd annual J.P. Morgan Healthcare Conference talked up value-based pricing, emerging market strategies, complex generics and new technology, from bedside devices and genetic sequencers to first-in-class mechanisms of action. Company ... [Published Pharmaceutical Executive - Jan 20 2014]

More Content

All (17) | News (17) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
CEO’s Letter: The stubborn facts about the 100 ... [Published CRO - Jul 09 2014]
Japan approves Daklinza, Sunvepra to treat HCV [Published Orthopedics Today - Jul 08 2014]
Bristol-Myers Squibb Treatment for Hepatitis C ... [Published Zolmax News - Jul 07 2014]
Bristol-Myers' hep C combo wins Japanese OK, le... [Published FierceBiotech - Jul 07 2014]
Bristol-Myers Squibb's Daklinza, Sunvepra all-o... [Published FirstWord Pharma - Jul 07 2014]
Eliquis scores DVT/PE recommendation in Europe [Published FiercePharma - Jun 27 2014]
Giovanni Caforio, M.D., Appointed Chief Operati... [Published NewsRX - Jun 20 2014]
U.K. price watchdog weighs in on BMS melanoma b... [Published FiercePharma - Jun 13 2014]
Bristol-Myers Squibb names new chief operating ... [Published Zenopa - Jun 10 2014]
Giovanni Caforio appointed Bristol-Myers Squibb... [Published Drug Store News - Jun 09 2014]
Bristol-Myers Squibb Appoints Giovanni Caforio ... [Published RTTNews.com - Jun 09 2014]
DuPont Co. Sued for $1 Billion Over Genetic Tec... [Published Bloomberg - Jun 04 2014]
Bristol-Myers Squibb's (BMY) CEO John Elicker o... [Published The Street Latest - Apr 30 2014]
Bristol-Myers Squibb net earnings up by 54% in Q1 [Published PharmaBiz - Apr 30 2014]
Product Positioning 2.0 [Published Pharmaceutical Executive - Feb 05 2014]
Bristol-Myers Squibb net falls by 21.5% in Q4 [Published PharmaBiz - Jan 27 2014]
J.P. Morgan: Pharma’s Agenda for 2014 [Published Pharmaceutical Executive - Jan 20 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.